Evidence map›Paper›PMID 34676610›Full record

ArticleProtein science : a publication of the Protein Society2021

Crystal structure of the anti-CRISPR, AcrIIC4.

Gi Eob Kim, So Yeon Lee, Hyun Ho Park

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Keeping Cas9 out of the (R-)loop.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  3. AcrIIC4 inhibits type II-C Cas9 by preventing R-loop formation.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  4. Review
  5. Crystal structure of the anti-CRISPR, AcrIIC4.Protein science : a publication of the Protein Society · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gi Eob KimCollege of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.
So Yeon LeeCollege of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.
Hyun Ho ParkCollege of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.ORCID 0000-0001-9928-0847

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clustered regularly interspaced short palindromic repeats (CRISPRs)-CRISPR-associated protein systems are bacterial and archaeal defense mechanisms against invading elements such as phages and viruses. To overcome these defense systems, phages and viruses have developed inhibitors called anti-CRISPRs (Acrs) that are capable of inhibiting the host CRISPR-Cas system via different mechanisms. Although the inhibitory mechanisms of AcrIIC1, AcrIIC2, and AcrIIC3 have been revealed, the inhibitory mechanisms of AcrIIC4 and AcrIIC5 have not been fully understood and structural data are unavailable. In this study, we elucidated the crystal structure of Type IIC anti-CRISPR protein, AcrIIC4. Our structural analysis revealed that AcrIIC4 exhibited a helical bundle fold comprising four helixes. Further biochemical and biophysical analyses showed that AcrIIC4 formed a monomer in solution, and monomeric AcrIIC4 directly interacted with Cas9 and Cas9/sgRNA complex. Discovery of the structure of AcrIIC4 and their interaction mode on Cas9 will help us elucidate the diversity in the inhibitory mechanisms of the Acr protein family.

Indexed as

CRISPR-Cas SystemsAntibiosisBacterial ProteinsBinding SitesCloning, MolecularCRISPR-Associated Protein 9Crystallography, X-RayDNAEscherichia coliGene EditingGene ExpressionGenetic VectorsHaemophilus parainfluenzaeModels, MolecularNeisseria meningitidisProtein BindingBacterial ProteinsCRISPR-Associated Protein 9DNARecombinant ProteinsRNA, Guide, CRISPR-Cas SystemsAcrIIC4anti-CRISPR proteinsCRISPR-Cas systemcrystal structuregene editing

Identifiers

PMID34676610
PMCPMC8605368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.